12-2634330-G-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP2BS2
The ENST00000399655.6(CACNA1C):c.3862G>T(p.Ala1288Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000139 in 1,581,328 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1288T) has been classified as Likely benign.
Frequency
Consequence
ENST00000399655.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.3862G>T | p.Ala1288Ser | missense_variant | 30/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.3912+618G>T | intron_variant | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399655.6 | c.3862G>T | p.Ala1288Ser | missense_variant | 30/47 | 1 | NM_000719.7 | ENSP00000382563 | ||
CACNA1C | ENST00000399603.6 | c.3912+618G>T | intron_variant | 5 | NM_001167623.2 | ENSP00000382512 |
Frequencies
GnomAD3 genomes AF: 0.00000663 AC: 1AN: 150724Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000144 AC: 3AN: 207986Hom.: 0 AF XY: 0.0000180 AC XY: 2AN XY: 111214
GnomAD4 exome AF: 0.0000147 AC: 21AN: 1430604Hom.: 0 Cov.: 29 AF XY: 0.0000113 AC XY: 8AN XY: 708660
GnomAD4 genome AF: 0.00000663 AC: 1AN: 150724Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 73486
ClinVar
Submissions by phenotype
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 05, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 1288 of the CACNA1C protein (p.Ala1288Ser). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 14, 2024 | The p.A1288S variant (also known as c.3862G>T), located in coding exon 30 of the CACNA1C gene, results from a G to T substitution at nucleotide position 3862. The alanine at codon 1288 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, the association of this alteration with CACNA1C-related neurodevelopmental disorder is unknown; however, the association of this alteration with Timothy syndrome or long QT syndrome is unlikely. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at